Acumen Pharmaceuticals (ABOS) vs Black Titan (BTTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Acumen Pharmaceuticals is the larger company by market cap ($151.9 million vs $6.8 million), about 22.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABOS | BTTC |
|---|---|---|
| Share price | $2.10 | $0.495 |
| Market cap | $151.87M | $6.78M |
| 1-day change | 0.00% | -3.51% |
| YTD return | -0.47% | — |
| 1-year return | +11.70% | — |
| 5-year return | -84.50% | — |
| EPS (TTM) | $-1.64 | $-0.46 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.60 | $10.05 |
| 52-week low | $1.50 | $0.342 |
| Distance from 52-week high | -41.67% | -95.07% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +261.90% | — |
| Average volume | 439.10K | 11.84M |
| Shares outstanding | 72.32M | 13.70M |
| Employees | 60 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Acumen Pharmaceuticals is about 22.4 times larger than Black Titan by market value ($151.87M vs $6.78M).
About Acumen Pharmaceuticals
ABOS stock →Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. It focuses on advancing a targeted immunotherapy drug candidate, sabirnetug (ACU193), which is in its Phase 2 ALTITUDE-AD clinical trial to target toxic soluble amyloid beta oligomers.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 60 employees
ABOS vs BTTC FAQ
Which is bigger, Acumen Pharmaceuticals or Black Titan?
Acumen Pharmaceuticals (ABOS) is larger, with a market capitalization of $151.87M compared with $6.78M for Black Titan (BTTC).
Are Acumen Pharmaceuticals and Black Titan in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.